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Abstract  
Seventy four Reference Sites of the European Innovation 
Partnership on Active and Healthy Ageing (EIP on AHA) 
have been recognised by the European Commission in 
2016 for their commitment to excellence in investing and 
scaling up innovative solutions for active and healthy 
ageing. The Reference Site Collaborative Network 
(RSCN) brings together the EIP on AHA Reference Sites 
awarded by the European Commission, and Candidate 
Reference Sites into a single forum. The overarching goals 
are to promote cooperation, share and transfer good 
practice and solutions in the development and scaling up 
of health and care strategies, policies and service delivery 
models, while at the same time supporting the action 
groups in their work. The RSCN aspires to be recognized 
by the EU Commission as the principal forum and 
authority representing all EIP on AHA Reference Sites. 
The RSCN will contribute to achieve the goals of the EIP 
on AHA by improving health and care outcomes for 
citizens across Europe, and the development of sustainable 
economic growth and the creation of jobs. 
 
Abbreviations 
AHA: active and healthy ageing 
EIP: European Innovation Partnership 
EIP on AHA: European Innovation Partnership on Active and 
Healthy Ageing 
EU: European Union 
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EC: European Commission 
RS: Reference Site 
RSCN: Reference Site Collaborative Network 
 
Key words  
Active and healthy ageing, European Innovation 
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I. INTRODUCTION 
 
As populations continue to grow older it is important to 
support the process of ageing well, active and healthy, that 
is a priority objective [1]. The broad concept of active and 
healthy ageing (AHA) is the process of optimizing 
opportunities for health and social care to increase healthy 
life expectancy, healthy life years and quality of life for all 
people as they age [2,3]. AHA allows people to realize their 
potential for physical, social and mental wellbeing 
throughout the life course [4]. AHA also contributes to the 
sustainability of our health and social systems, reducing 
dependency and disability. 
To tackle the potential and challenges of ageing in the EU, 
the EC - within its Innovation Union policy- launched the 
European Innovation Partnership on Active and Healthy 
Ageing (EIP on AHA) [5,6] in 2012. It continues to pursue a 
triple win for Europe 
(https://webgate.ec.europa.eu/eipaha/): 
• Enabling EU citizens to lead healthy, active and 
independent lives while ageing. 
• Improving the sustainability and efficiency of social and 
health care systems. 
• Boosting and improving the competitiveness of the 
markets for innovative products and services, responding 
to the ageing challenge.. 
The EIP on AHA brings together public and private 
stakeholders to accelerate the deployment of major 
innovations by committing them to undertaking supply 
and demand side measures across sectors and the entire 
innovation chain. EIP on AHA does not replace existing 
decision-making processes. However, regional 
commitments to EIP on AHA can influence and inform 
policy decisions, support change management strategies 
and service delivery models, and therefore identify 
opportunities, and potential partners, under a range of 
funding programmes for the development of evidence 
based innovative solutions. 
The EIP on AHA is a distinctive opportunity to help 
deliver on the policy objectives of the Europe 2020 
flagships. Its objectives and approach are also in line with 
the principles and goals of the EU Health Strategy 
"Together for Health".  
 
II. REFERENCE SITES OF THE EUROPEAN 
INNOVATION PARTNERSHIP ON ACTIVE AND 
HEALTHY AGEING 
 
Reference Sites (RS) are "ecosystems which comprise 
various players (including regional and/or local 
government authorities, cities, hospitals/care 
organisations, industry, SMEs and/or start-ups, research 
and innovation organisations including universities and 
civil society), that jointly implement a comprehensive, 
innovation-based approach to AHA, and can give evidence 
and concrete illustrations of the impact of such approaches 
on the ground" (https://ec.europa.eu/eip/ageing/reference-
sites_en). 
In 2012, 32 RS were awarded by the EU. Networking is a 
fundamental part of the EIP on AHA. RSs are pioneering 
together some of the most advanced innovative solutions 
to improve the lives of its ageing populations and through 
the partnership. Through “maturity assessment”, referred 
to the extent to which the local ecosystem for AHA is 
developed, integrated and established, joint projects [7-
14,15,16,17,18],  meetings [3,11,19-22], scaling up activities [23], 
conferences and workshops (www.whinn.dk and 
https://syddansksundhedsinnovationeipaha.wordpress.com
/news/ and 
http://www.southdenmark.be/media/1701/dacob-
upscaling-workshops-introduktion.pdf) and study-visits 
(http://www.syddansksundhedsinnovation.dk/service-
menu/aktuelt/2016/juli-dec2016/500-gaester-fra-20-
forskellige-lande-besoegte-syddansk-sundhedsinnovation-
i-2016/) collaboration has allowed RS to share good 
practices and build cross border activities in a way that 
maximizes outcomes and reduces risks associated to 
investing in innovation to deliver a holistic approach to the 
achievement of the EIP on AHA objectives.  
Revised criteria were introduced in 2016 to define and 
evaluate the RS (http://ec.europa.eu/research/innovation-
union/pdf/active-healthy-ageing/2016_call_rs.pdf). One of 
the cornerstones within this was the requirement for the 
RS to build, and demonstrate that cross sectoral 
coalitions/alliances/partnerships have been implemented at 
regional level which support the research, development 
and adoption of new solutions and enable the scaling up 
and transferability of good practices within their region.  
Seventy four RSs have been recognised in 2016 for their 
commitment to excellence in investing and scaling up 
innovative digital solutions for AHA (Table 1). Together 
the 74 RSs have committed to invest over € 4 billion in the 
next three years in the deployment and scaling up of 
digital innovation for AHA. This investment is expected to 
benefit over 5 million people in the next 3 years. It will 
also lay the foundations for a scalable EU market for 
digital innovation services and products meeting the needs 
of Europe's ageing population and their carers. 
Cumulatively, the RS commit to invest in specific main 
areas of digital innovation:  
• Health promotion through personalised coaching and 
citizens empowerment; 
• Disease prevention through big data and risk stratification;  
• Digitally-enabled platforms for chronic disease 
management; 
• Tools for integrating hospital care and community/social 
care; 
• Programmes for upgrading tele-health and tele-care 
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solutions to support independent living and quality of life 
of the ageing population; 
• Multidisciplinary education, training and life-long learning 
innovative programs.  
 
(Table 1. List and contacts of Reference Sites) 
 
III. REFERENCE SITE COLLABORATIVE NETWORK 
 
It is beneficial to contribute to a continuous and 
constructive dialogue among the RS. Such a dialogue  
takes place participating in a collaborative network on an 
equal basis, regardless of their political and administrative 
structure. The Reference Site Collaborative Network 
(RSCN) brings together all EIP on AHA regions given RS 
status by the EC, and Candidate RS into a single forum.  
 
A. Vision 
The RSCN aspires to be continually recognised by the EC 
as the principal forum and authority representing all EIP 
on AHA RS, and to establish connections with and across 
the Actions Groups (AG) in order to promote AHA. Our 
vision is to help our members accelerate the development, 
deployment and adoption of innovative health and social 
care solutions, proven AHA delivery models and digital 
solutions that provide real impact and contribute towards 
sustainability of services.   
 
B. Strategy 
The overarching goals of the RSCN are to promote 
cooperation, share and transfer good practice in the 
implementationand scaling up of health and care 
strategies, policies and service delivery models. More 
specifically the RSCN will: 
 Facilitate members to develop, share and adopt good 
practice and innovative solutions and technologies at 
scale; 
 Influence and provide strategic input to bodies such as 
the EC, WHO, building on the knowledge and 
expertise of our regional members; 
 Provide thought leadership through expert working 
groups; 
 Provide a range of advisory and management services 
to members. 
 
C. Governance 
Reference Sites have elected an RSCN Executive Board  
(EB) composed 8 Strategic Members and 2 Full Members 
appointed by the General Assembly (GA). All RS are 
eligible to participate in the GA, and one vote is allocated 
to each RS when conducting business. The EB has 
appointed two co- Chairs, two Deputy Vice Chairs and a 
Treasurer (Table 2). 
 (Table 2. RSCN Executive Baord) 
 
EB Members are elected for 3 years and may be re-elected 
for one additional term. No Member may serve more than 
2 consecutive terms. The EB meets at least twice per year.  
The EB determines the strategies and actions of the 
RSCN. It will identify specific thematic Working Groups 
aimed at producing common operational projects in 
support of the EIP on AHA objectives. 
The Secretariat of the RSCN will inform RS of new policy 
and funding developments; co-ordination of twinning and 
knowledge sharing events; establishing and maintaining 
links with candidate RS and Regions, the EU institutions 
and other organisations supporting EIP on AHA. The 
Secretariat shall be agreed and appointed by the EB. The 
secretariat is currently based in Montpellier (MACVIA 
France go.rscn@outlook.com) 
  
D. Membership 
There are 5 categories of RSCN members (Table 3). 
All RS are full members of the RSCN and one of their 
representatives will be a voting member at the GA. This 
representative will sit on the RSCN GA and will act on 
behalf of all the stakeholder organisations within the RS 
and ensure their views are represented. They will also be 
responsible for disseminating communications from the 
RSCN within their RS. 
 (Table 3. RSCN Membership categories) 
 
IV. CURRENT ACTIONS  
 
A. Transfer of innovation: Twinning support scheme   
The 2016 Transfer of Innovation Twinning Support 
Scheme was a pilot scheme launched by the EC with the 
support of the ScaleAHA Team (http://www.scale-
aha.eu/home.html) to support regional deployment of 
innovation by partners of the EIP on AHA through the 
reimbursement of expenses incurred in the transfer of 
innovative practices. Under this scheme, twenty pairs of 
RS (Table 4) have been provided with financial support 
for study visits between experts in the adopting and 
originator organisations. Twinning project represents an 
opportunity for both patients and healthcare professionals, 
cause it facilitate the assessment of impact of digitally 
enabled innovations in a uniform way. 
 (Table 4. List of Twinnings) 
 
MThe first results are promising, and the process should 
be further refined taking into consideration lessons learnt 
and recommendations by the pilot twinning organisations. 
The final report 
(http://www.scaleaha.eu/fileadmin/scaleaha/documents/sc
aleaha_d5.4_finalstudyreport.pdf) presents interim results 
of the twinning activities, which include discussions about 
barriers and challenges faced, success factors leveraged, 
plans and strategies on moving forward, and 
recommendations for the future. It also presented twinning 
archetypes (Figure 1). 
 
 (Figure 1. Twinning archetypes) 
 
The ScaleAHA team also provided a number of 
recommendations coming from the RS and the twinning 
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activities for policy makers, and for better organisation of 
future initiatives such as a second call for transfer of 
innovation. Other recommendations concerned future calls 
for RS, funding utilization support and the assessment of 
impact of digitally enabled innovations in a uniform way. 
 
 
B. Interactions with the Commission 
The RSCN is registered at the EC Transparency Register 
(ID: 583454420450-89) since January 2016. The 
Transparency Register has been set up to answer core 
questions such as what interests are being pursued, by 
whom and with what budgets. The system is operated 
jointly by the European Parliament and the EC. The RSCN 
is a member of the eHealth Stakeholder Group (eHSG), set 
up by DG SANTE and DG CNECT through a call for 
expression of interest in January 2016. Currently 
Andalusia (representing RSCN as its vice-chair) is 
rapporteur for the working group on Care Continuum 
within the eHSG. RSCN is responding to public 
consultations and contributing to the decision-making 
process at the EC level. 
 
C. Interactions with the CSA 
The WE4AHA Coordination and Support Action (CSA is 
aimed at advancing the effective, large-scale uptake and 
impact of Digital Innovation for AHA, mobilizing relevant 
stakeholders to help develop and implement three EU 
guided activities: Innovation 2 Market, Blueprint on 
Digital Transformation of Health and Care for the Ageing 
Society, and EIP on AHA. Hence, the RSCN has a 
bidirectional connection with the CSA: is supported by the 
CSA for some specific horizontal activities and ensures 
that the EU guided activities are developed by taking 
advantage of the contributions of all partners of the EIP on 
AHA. 
Within the WE4AHA CSA, the RSCN will be responsible 
for some actions: 
1. Twinning programs for large scale-up digital solutions; 
2. Organize at least 6 thematic workshops including: 
a. Health Tourism Brussels, 27 February 2018): 
leader: PROMIS, 
b. POLLAR (CoP 2019), 
c. Thematic workshops in collaboration with 
EUREGHA, 
d. A call will be opened each year to obtain topics 
and locations from RS members. Part of funding will 
be available for these events; 
1. 3. Support for event of regional stakeholders to be 
replicated across the EU; 
2. 4. Help to launch the next call for RS;  
3. 5. Identification of the key elements to map the quadruple 
helix ecosystem;. 
4. 6. Evaluation of RS progress; 
5. 7. Release content for dissemination activities. 
 
D. Interactions with the other EU Organisations 
The RSCN recognizes the benefit to be achieved from 
working closely with other EU networks and partners, 
particularly those whose aims, and goals overlap with its 
own. Nick Batey (RSCN) connects the work of the RSCN 
with that of EUREGHA. The RSCN also works with the 
ECHAlliance  as part of the Coalition of the Willing 
(CoW). 
 
E. Current RSCN involvement in EC projects 
The RSCN is currently (December 2018) involved in three 
European Projects. VIGOUR, a 3rd Health Programme 
project, seeks to support care authorities in progressing the 
transformation of their health and care systems to provide 
sustainable models for integrated care. 
DigitalHealthEurope, a H2020 CSA project, will provide 
comprehensive, centralized support to the digital 
transformation of health and care (DTHC) priorities of the 
Digital Single Market. The project will support large-scale 
deployment of digital solutions for person-centered 
integrated care. EURIPHI, also a H2020 CSA project, has 
as its vision to build out around the Most Economic 
Advantageous Tender (MEAT) Value Based Procurement 
framework which will be made accessible with adaptions 
necessary to support the cross-border PPI leading to 
“MEAT Value Based PPI”.  
The inclusion of the RSCN in these projects highlights the 
strategic position of the organisation within the 
consortiums, acting as a catalyst to foster scaling-up across 
regions and countries. With the RSCN, the projects have 
first-hand access not only to regions which are innovation 
leaders, but also to regions who are less mature in their  
person-centred integrated care. The RSCN closely support 
tasks related to identifying best practices by helping to 
assess the characteristics and the impact of the innovative 
approach. It will facilitate partnerships with other regions 
for the updating of existing guidance material, the 
conduction of twinning activities and wider scaling-up 
guidance.  
The RSCN is aiming at answering to the need for a 
collaborative approach to facilitate joint reflection and 
action in sharing and transferring best practices in the 
development and scaling up of health and care strategies, 
policies and service delivery models.   
 
IV. SOME EXAMPLES OF RSCN ACHIEVEMENTS 
  
A. Programma Mattone Internazionale Salute 
Established in 2013 as a project of the MoH in 2016, 
Programma Mattone Internazionale Salute (ProMIS) 
became an institutional structure aimed at creating  a 
permanent dialogue and synergies among Italian Regions, 
as well as with the EU health policies and systems. 
ProMIS provides opportunities of information and 
discussion, organizing workshops and conferences, 
satisfying the needs jointly expressed by Italian regions. It 
also disseminates European calls, stimulating the 
participation of Italian clusters to the consortia and 
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supporting the regions in the coordination for the 
participation to the calls. The program has developed 
preparatory activities to support the Regions in their 
application to become a RS and to submit commitments, 
explaining the details of the calls, facilitating the access to 
the useful information in order to prepare the proposal, 
thus making the Italian Regions collaborate at their best 
with the other European Regions [24]. Among the 74 RSs 
awarded by the EC in 2016, 11 are Italian Regions that 
have been assigned one or more stars according to the 
maturity: Campania, Emilia Romagna, Friuli Venezia 
Giulia, Lazio, Liguria, Lombardy, Piedmont, Puglia, 
Tuscany, Veneto and the Autonomous Province of Trento. 
In order to define a common RS “model” and give 
Regions a structure to assess the effectiveness/validity of 
their strategies, Italian Regions agreed to draft a document 
“Methodology for the Italian Reference Sites: Which 
organizational structure?” where RS management, 
methods and tools are described, supported by validation 
elements of the RS model at European level. Every year 
the updated version of "EIP-AHA Italy: the Italian 
experience in the framework of the European Innovation 
Partnership on Active and Healthy Ageing" is also 
published, which is the focal document describing Italian 
RS activity and all the relevant European and national 
initiatives linked with EIP-AHA.  
 
B. Global Alliance Chronic Respiratory Diseases 
Regional Network (Turkey)  
The Global Alliance Chronic Respiratory Diseases 
Regional Network is the National Control Program of 
Turkish MoH on chronic airway disease with 64 
collaborating parties which can be used as a model for EIP 
on AHA RS [25,26]. 
 
C. Coimbra activities of the RSCN  
Instituto Pedro Nunes, a member of Ageing@Coimbra 
reference site, was the local organizer of the Ambient 
Assisted Living Forum 2017 (2-4 October, 2017) [27]. The 
program of the meeting included the workshop “Bridges 
between Europe – integrating health and social care 
towards innovation” with representatives of RSCN 
(Maddalena Illario and João Malva). The RS 
Ageing@Coimbra has been leader of the innovative 
activity joining senior citizens and innovators in the 
Forum. From local Third Age Universities and nursing 
homes, 120 +65 people have been invited to visit the 
technological exhibitors in the Forum and to perform the 
evaluation of the technologies. At the end of this exercise, 
the most favorite technologies were ranked and a winner 
was selected. All the exposed technologies received an 
assessment report, including recommendations provided 
by the end-users [28].    
 
D. Mobile Airways Sentinel network 
(MASK@Twinning) 
The aim of MASK@Twinning is to transfer innovation 
from an App developed by the MACVIA-France (MASK, 
TLR9) [29-35] to other RSs [36]. MASK follows the criteria 
for Good Practices of the CHRODIS Joint Action [37] and 
its privacy is in line with the Article 28 EU General Data 
Protection Regulation (EU-GDPR) [38]. The phenotypic 
characteristics of rhinitis and asthma multimorbidity [39] in 
adults and the elderly are compared using validated 
information and communication technology (ICT) tools 
(i.e. the Allergy Diary and CARAT: Control of Allergic 
Rhinitis and Asthma Test) in 29 RSs, regions or countries 
across Europe and beyond. This will improve 
understanding, assessment of burden, diagnosis and 
management of rhinitis in the elderly by comparison with 
an adult population. Specific objectives are to: (i) assess 
the percentage of adults and elderly who are able to use 
the Allergy Diary, (ii) study phenotypic characteristics and 
treatment over a period of one year of rhinitis and asthma 
multimorbidity at baseline (cross-sectional study) and (iii) 
follow-up using visual analogue scale (VAS). This part of 
the study may provide some insight into the differences 
between the elderly and adults in terms of response to 
treatment and practice as well as precision medicine [40]. 
Finally (iv) work productivity is examined in adults. The 
first results of MASK@Twinning are very promising and 
over 400 patients have been recruited. A pilot study 
showed that the questionnaire for physicians (EUFOREA-
ARIA website, www.euforea.eu/) [40]  is appropriate. This 
project also allowed MASK to be deployed in the entire 
country with the national society in France and Germany. 
Moreover, MASK@Twinning has been endorsed by the 
European Academy of Allergy and Clinical Immunology 
(EAACI), the European Respiratory Society (ERS), the 
International Primary Care Airways Group (IPCRG), two 
major European patients’ organisations (EFA, European 
Federation of Allergy and Airways Diseases Patients’ 
Associations and ELF, European Lung Foundation) and an 
international patient’s organization (GAAP) [41] . It is 
WHO Global Alliance against Chronic Respiratory 
Diseases (GARD) demonstration project. 
MASK@Twinning centers have been included in a 2018 
EIT Health Innovation-by-Design project (POLLAR: 
Impact of Air Pollution in Asthma and Rhinitis).  
  
E. Participation of RSCN to International Projects 
RSCN co-sponsored a WHO-GARD meeting in Brussels 
on the impact of air pollution in chronic respiratory 
diseases (10th November, 2018). It is also co-sponsoring 
an EU Summit held by the Minister of Health of Lithuania 
on the management of chronic respiratory diseases 
(Vilnius, 23rd March, 2018) and the consensus meeting on 
self-management in airways diseases (EIT Health, WHO 
GARD), December 2018. 
 
V. RSCN CHANGE MANAGEMENT MODEL 
The RSCN follows a change management strategy to 
accomplish its vision and mission. Although theories may 
seem abstract and impractical, they can help to solve 
common problems [42]. The 3-Step model of the Lewin's 
approach [43] dominated the change management theory 
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and practice for over 50 years. Although criticized, it is 
still used [44,45] and has great interest in its simplicity [46]. 
The model posits the 3-step sequence of change: 
unfreezing, moving, and refreezing [45,47]. Kotter [48] has 
added to the collective change knowledge to expand upon 
Lewin’s original Theory (Table 5) [43].  
 
 (Table 5. The Kotter’s model of change management 
Adapted from [45]) 
 
Many different projects have shown the importance of the 
EIP on AHA to achieve its goals. It is, however, urgent 
that the concept of AHA is more widely and rapidly 
translated into practice. The RSCN is one of the key tools 
of the EIP on AHA to transfer concepts to practice 
(Step1). 
The 74 RS of the EIP on AHA represent an exceptional 
group committed to the deployment of AHA in EU regions 
and beyond. The RSCN represents a guiding coalition lead 
by its executive board and strategic members (Step2).   
The RSCN vision and strategy are clearly defined (Step 3). 
The change vision is disseminated through a dedicated 
website  and using all means for communication. This 
paper is an important communication tool. A newsletter 
will be regularly published (Step 4). 
Organizational processes and structures are in place and an 
ASBL is set and will help to remove the obstacles 
involved in the process of change. The Regional Events 
will help to empower others (Step 5).  
Short term wins have already been obtained (see chapter 
4) and a strategy for next year is in place (Step 6).    
The goals of step 7 [48] are to achieve continuous 
improvement by analysing the success stories individually 
and improving from those individual experiences.   
The goals of step 8 [48] are: 
1. Discuss the successful stories related to change initiatives 
widely. 
2. Ensure that the change becomes an integral part of the 
practice and is highly visible. 
3. Ensure that the support of the existing as well as the new 
leaders continues to extend towards the change. 
 
 
REFERENCES 
 
[1] Depp CA, Jeste DV. Definitions and predictors of 
successful aging: a comprehensive review of larger 
quantitative studies. Am J Geriatr Psychiatry 2006;14:6-
20. 
[2] Rechel B, Grundy E, Robine JM, et al. Ageing in the 
European Union. Lancet 2013;381:1312-22. 
[3] Bousquet J, Kuh D, Bewick M, et al. Operational 
definition of active and healthy ageing (AHA): Framework 
concensus. J Nutr Health Aging 2015;19:955-60. 
[4] Kuh D, Cooper R, Hardy R, Richards M, Ben-Shlomo 
Y. A life course approach to healthy ageing. Oxford 2014. 
[5] Garcia-Lizana F. European innovation partnership on 
active and healthy aging: moving from policy to action. 
Gac Sanit 2013;27:459-62. 
[6] Bousquet J, Michel J, Standberg T, Crooks G, 
Iakovidis I, Gomez M. The European Innovation 
Partnership on Active and Healthy Ageing: the European 
Geriatric Medicine introduces the EIP on AHA Column. 
Eur Geriatr Med 2014;5:361-2. 
[7] de-Manuel-Keenoy E, David M, Mora J, et al. 
Activation of Stratification Strategies and Results of the 
interventions on frail patients of Healthcare Services 
(ASSEHS) DG Sanco ProjectNo. 2013 12 04. Eur Geriatr 
Med 2014;5:342-6. 
[8] Keijser W, de-Manuel-Keenoy E, d’Angelantonio M, 
et al. DG Connect funded projects on information and 
communication technologies (ICT) for old age people: 
Beyond Silos, CareWell and SmartCare. J Nutr Health 
Aging 2016;20:1024-33. 
[9] Bousquet J, Addis A, Adcock I, et al. Integrated care 
pathways for airway diseases (AIRWAYS-ICPs). Eur 
Respir J 2014;44:304-23. 
[10] Bourret R, Bousquet J, J M, et al. MASK rhinitis, a 
single tool for integrated care pathways in allergic rhinitis. 
World Hosp Health Serv 2015;51:36-9. 
[11] Bousquet J, Kowalski M, Michel J. The senioral 
policy in Poland uses the expertise of the European 
Innovation Partnership on Active and Healthy Ageing. Eur 
Geriatr Med 2015;6:in press. 
[12] Liotta G, O'Caoimh R, Gilardi F, et al. Assessment of 
frailty in community-dwelling older adults residents in the 
Lazio region (Italy): A model to plan regional community-
based services. Arch Gerontol Geriatr 2017;68:1-7. 
[13] van Velsen L, Illario M, Jansen-Kosterink S, et al. A 
Community-Based, Technology-Supported Health Service 
for Detecting and Preventing Frailty among Older Adults: 
A Participatory Design Development Process. J Aging Res 
2015;2015:216084. 
[14] Menditto E, Guerriero F, Orlando V, et al. Self-
Assessment of Adherence to Medication: A Case Study in 
Campania Region Community-Dwelling Population. J 
Aging Res 2015;2015:682503. 
[15] Caoimh RO, Weathers E, O’Donnell R, et al. The 
Community Assessment of Risk Screening and Treatment 
Strategies (CARTS) – An Integrated Care Pathway to 
Manage Frailty and Functional Decline in Community 
Dwelling Older Adults. In: al HMe, ed. ICT4AgeingWell, 
CCIS 578. Switzerland: Springer International Publishing; 
2016:1-16. 
[16] Paul C, Teixeira L, Azevedo MJ, et al. Perceived Risk 
of Mental Health Problems in Primary Care. Front Aging 
Neurosci 2015;7:212. 
[17] Liotta G, Orfila F, Vollenbroek-Hutten M, et al. The 
European Innovation Partnership on Active and Healthy 
Ageing Synergies: Protocol for a Prospective 
Observational Study to Measure the Impact of a 
Community-Based Program on Prevention and Mitigation 
of Frailty (ICP - PMF) in Community-Dwelling Older 
Adults. Transl Med UniSa 2016;15:53-66. 
Translational Medicine @ UniSa-ISSN 2239-9747  2019, 19(11): 66-81 
Università degli Studi di Salerno   75 
 
[18] Bousquet J, Bewick M, Cano A, et al. Building 
Bridges for Innovation in Ageing: Synergies between 
Action Groups of the EIP on AHA. J Nutr Health Aging 
2017;21:92-104. 
[19] Bousquet J, Anto JM, Berkouk K, et al. 
Developmental determinants in non-communicable 
chronic diseases and ageing. Thorax 2015;70:595-7. 
[20] Bousquet J, Malva J, Nogues M, et al. Operational 
definition of active and healthy ageing (AHA): The 
European Innovation Partnership (EIP) on AHA Reference 
Site questionnaire J Am Med Dir Assoc 2015;16:1020-6. 
[21] Bousquet J, Rosado Pinto J, Barbara C, et al. Portugal 
at the cross road of international chronic respiratory 
programmes. Rev Port Pneumol (2006) 2015;21:230-2. 
[22] Samolinski B, Raciborski F, Bousquet J, et al. 
Development of Senioral Policy in Poland Eur Geriatr 
Med 2015;7:in press. 
[23] Bousquet J, Farrell J, Crooks G, et al. Scaling up 
strategies of the chronic respiratory disease programme of 
the European Innovation Partnership on Active and 
Healthy Ageing (Action Plan B3: Area 5). Clin Transl 
Allergy 2016;6:29. 
[24] Illario M, De Luca V, Tramontano G, Menditto E, 
Iaccarino G, Bertorello L, Palummeri E, Romano V, Moda 
G, Maggio M, Barbolini M, Leonardini L, Addis A. Italian 
EIP-AHA Working Group. The Italian reference sites of 
the European innovation partnership on active and healthy 
ageing: Progetto Mattone Internazionale as an enabling 
factor. Ann Ist Super Sanita 2017; 53(1):60-69. doi: 
10.4415/ANN_17_01_12 
[25] Yorgancioglu A, Turktas H, Kalayci O, et al. The 
WHO global alliance against chronic respiratory diseases 
in Turkey (GARD Turkey). Tuberk Toraks 2009;57:439-
52. 
[26] Yorgancioglu A, Yardim N, Ergun P, et al. 
Integration of GARD Turkey national program with other 
non-communicable diseases plans in Turkey. Tuberk 
Toraks 2010;58:213-28. 
[27] Malva JO, Amado A, Rodrigues A, et al. The 
Quadruple Helix-Based Innovation Model of Reference 
Sites for Active and Healthy Ageing in Europe: The 
Ageing@Coimbra Case Study. Front Med 2018;5:132. 
[28] Malva J, Amado A, Rodrigues A, et al. The quadruple 
helix-based innovation model of Reference Sites for 
Active and Healthy Ageing in Europe: The 
Ageing@Coimbra case study. Front Med 2018;in press. 
[29] Bousquet J, Arnavielhe S, Bedbrook A, et al. The 
ARIA score of allergic rhinitis using mobile technology 
correlates with quality-of-life: The MASK study. Allergy 
2017. 
[30] Bousquet J, Bewick M, Arnavielhe S, et al. Work 
productivity in rhinitis using cell phones: The MASK pilot 
study. Allergy 2017;72:1475-84. 
[31] Bousquet J, Caimmi DP, Bedbrook A, et al. Pilot 
study of mobile phone technology in allergic rhinitis in 
European countries: the MASK-rhinitis study. Allergy 
2017;72:857-65. 
[32] Bousquet J, VandenPlas O, Bewick M, et al. Work 
Productivity and Activity Impairment Allergic Specific 
(WPAI-AS) Questionnaire using Mobile Technology: The 
MASK study. J Investig Allergol Clin Immunol 2017. 
[33] Caimmi D, Baiz N, Tanno LK, et al. Validation of the 
MASK-rhinitis visual analogue scale on smartphone 
screens to assess allergic rhinitis control. Clin Exp Allergy 
2017;47:1526-33. 
[34] Bousquet J, Hellings PW, Agache I, et al. ARIA 
2016: Care pathways implementing emerging technologies 
for predictive medicine in rhinitis and asthma across the 
life cycle. Clin Transl Allergy 2016;6:47. 
[35] Bousquet J, Arnavielhe S, Bedbrook A, et al. 
Treatment of allergic rhinitis using mobile technology 
with real world data: The MASK observational pilot study. 
Allergy 2018; In press. 
[36] Bousquet J, Agache I, Aliberti MR, et al. Transfer of 
innovation on allergic rhinitis and asthma multimorbidity 
in the elderly (MACVIA-ARIA) - EIP on AHA Twinning 
Reference Site (GARD research demonstration project). 
Allergy 2018;73:77-92. 
[37] Bousquet J, Onorato GL, Bachert C, et al. CHRODIS 
criteria applied to the MASK (MACVIA-ARIA Sentinel 
NetworK) Good Practice in allergic rhinitis: a SUNFRAIL 
report. Clin Transl Allergy 2017;7:37. 
[38] Article 28 EU General Data Protection Regulation 
(EU-GDPR). [Internet] 2018 Available from: 
https://wwweugdprorg/. 
[39] Cingi C, Gevaert P, Mosges R, et al. Multi-
morbidities of allergic rhinitis in adults: European 
Academy of Allergy and Clinical Immunology Task Force 
Report. Clin Transl Allergy 2017;7:17. 
[40] Hellings PW, Fokkens WJ, Bachert C, et al. 
Positioning the Principles of Precision Medicine in Care 
Pathways for Allergic Rhinitis and Chronic Rhinosinusitis 
- an EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 
Allergy 2017;72:1297-305. 
[41] Hellings PW, Borrelli D, Pietikainen S, et al. 
European Summit on the Prevention and Self-
Management of Chronic Respiratory Diseases: report of 
the European Union Parliament Summit (29 March 2017). 
Clin Transl Allergy 2017;7:49. 
[42] Barrow JM, Toney-Butler TJ. Change, Management.  
StatPearls. Treasure Island (FL)2017. 
[43] Lewin K. Defining the'field at a given time. Psychol 
Rev 1943;50:292. 
[44] Burnes B. Kurt Lewin and the Planned Approach to 
Change: A Re-appraisal. J Manag Studies 2004;41:997-
1002. 
[45] Antwi M, Kale M. Change Management in 
Healthcare. Literature Review 2014. 
[46] Bamford D, Daniel S. A case study of change 
management effectiveness within the NHS. J Change 
manag 2005;5:391-406. 
[47] Bullock R, Batten D. It's just a phase we're going 
through: a review and synthesis of OD phase 
analysis. Group Org Manag 1985;10:383-412. 
[48] Kotter J. Leading change. Boston, USA: Harvard 
Business School Press; 1996. 
 
Translational Medicine @ UniSa-ISSN 2239-9747  2019, 19(11): 66-81 
Università degli Studi di Salerno   76 
 
  
 
Reference 
Site 
Country Main Contact 
Point 
Second Contact 
point or 
Coordinator 
1 Amsterdam 
Metropolitan 
Area 
The Netherlands Sabina van der 
Veen 
  
2 Andalusia Spain Ana Carriazo Mercedes Garcia 
3 Aragon Spain Juan I. Coll 
Clavero 
  
4 Arsenàl.IT - 
Veneto's 
Research 
Centre for 
eHealth 
Innovation 
Italy Claudio 
Saccavini 
  
5 Asturias Spain Nerea Eguren Ana Bernardo 
Suarèz 
6 Aust-Agder 
County and 
Vest-Agder 
County 
Norway Rune Fensli   
7 Baden-
Württemberg 
Germany Daniel Buhr   
8 Balearic 
Islands 
Spain Elena Cabeza   
9 Barcelona 
Province 
Spain Alejandra Millet 
Pi-Figueras 
  
10 Basque 
Country 
Spain Jon Darpón 
Sierra 
Esteban de 
Manuel Keenoy 
11 Campania Italy Maddalena 
Illario 
  
12 Catalonia Spain Antoni Dedeu 
Baraldes 
  
13 Centro Portugal Joao Malva Ana Abrunhosa 
14 City of 
Augsburg 
Germany Andreas W. 
Huber 
  
15 City of 
Badalona 
Spain Jordi Piera 
Jiménez 
  
16 City of 
Helsinki 
Finland  Sanna Hartman Mr. Heikki 
Kallasvaara 
Arja Peiponen 
17 City of 
Kraljevo 
Serbia Milan Vukovic   
18 City of 
Kuopio 
Finland Markku 
Tervahauta 
  
19 City of 
Liverpool 
United Kingdom Dave Horsfield   
20 City of Oulu Finland Anne Rännäli-
Kontturi 
 Salla Hirvonen 
21 City of Sofia Bulgaria Yanko 
Kuzmanov 
Stoicho 
Katsarov 
22 City of 
Terrassa 
Spain Manel Balcells 
Diaz 
  
23 City of 
Zagreb 
Croatia Antonija 
Balenović 
  
24 East of France France Valentin Ledroit    
25 Emilia- Italy Maria Luisa Papini Donato  
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Romagna Moro Brigida Marta 
26 Federal 
Ministry for 
Family 
Affairs, 
Senior 
Citizens, 
Women and 
Youth 
Germany Peter 
Kupferschmid 
  
27 Flanders Belgium Loes Houthuys   
28 Friuli Venezia 
Giulia 
Italy Arrigo 
Venchiarutti 
  
29 Galicia Spain Susana 
Fernandez 
Nocelo 
  
30 Global 
Alliance 
Chronic 
Respiratory 
Diseases 
Regional 
Network 
Turkey Arzu 
Yorgancıoglu 
  
31 Greater 
Manchester 
United Kingdom Amanda Risino   Paul Mc Garry 
32 Healthy 
Ageing 
Network 
Northern 
Netherlands 
The Netherlands Daan Bultje   
33 Heraklion-
Crete 
Greece Panayiotis 
Mitsias 
  
34  Île-de-France France Louis Potel   
35 Kiev-Zhitomir Ukraine Leonid 
Bogatyrchuk 
  
36 Kinzigtal Germany Dirk Günther   
37 Lazio Italy Ursula 
Kirchmayer 
  
38 Liguria Italy Lorenzo 
Bertorello 
  
39 Limburg Belgium Laura Visconti   
40 Lodz 
Province 
Poland Lucyna A. 
Wozniak 
  
41 Lombardy Italy Maurizio 
Bersani 
  
42 MACVIA 
France 
Network 
France Jean Bousquet   
43 Madrid Spain Teresa 
Chavarria 
Giménez 
  
44 Medical Delta The Netherlands Agaath Sluijter    
45 Metropolitan 
Area of Porto 
(Porto4Agein
g) 
 Portugal Elísio Costa   
46 Milan 
Metropolitan - 
Italy Maria Romano   
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Bergamo 
Province 
47 Region de 
Murcia 
Spain Beatriz 
Martínez-
Lozano Aranaga 
  
48 Norrbotten Sweden Lisa Lundgren    
49 North Brabant 
Province 
The Netherlands Peter Portheine   
50 North East 
England 
United Kingdom Graham 
Armitage 
  
51 North West 
Coast of 
England 
United Kingdom Phil Jennings Eleanor Garnett-
Bentley  
Andrew Cooper 
52 Northern 
Ireland 
United Kingdom Elaine Colgan    
53 Nouvelle-
Aquitaine 
France Carole Doucet   
54 Oberbergische
r Kreis 
Germany Wolfgang 
Goetzke 
Judith Brehm 
55 Olomouc Czech Republic Zdenek Gütter   
56 Pays De La 
Loire 
France Hajjam Jawad   
57 Piedmont Italy Valeria Romano   
58 Pirkanmaa Finland Anja Tuulonen   
70 Twente The Netherlands Miriam 
Vollenbroek-
Hutten 
  
71 Valencian 
Community 
Spain Charo Penadés Javier Gamez  
72 Wales United Kingdom Nick Batey   
73 West Flanders 
Province 
Belgium Inge Taillieu   
74 Yorkshire and 
the Humber 
United Kingdom Stephen 
Stericker 
  
75  Zealand Denmark Esther Bülow 
Davidsen 
  
Table 1. List and contacts of Reference Sites 
 
Co-chairs J Bousquet (MACVIA-France), M Illario (Campania) 
Vice-Chairs N Batey (Wales), A Carriazo (Andalucia) 
Treasurer J Malva (Ageing@Coimbra) 
Scientific adviser N Guldemond (Delta Medica, NL) 
Members E Colgan (Northern Ireland), J Hajjam (Pays de la Loire), M Perälä-Heape (Oulu, Finland) 
Adviser  J Farrell 
Table 2. RSCN Executive Baord 
 
 Membership Description Paying 
fee* 
Participation in 
GA, WG, 
conference 
Voting 
right at 
GA 
Ex Board 
member  
1 Full member Full membership is open to all 
RS approved by the European 
Commission  
No  Yes Yes Yes (up to 
2) 
2 Strategic 
member 
RS that take active and leading 
roles in the network 
In 
species 
Yes Yes Yes (but 
max 10) 
3 Honorary  Individuals distinguished in No Yes No No 
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member the fields of AHA  
 They are appointed by the 
GA upon proposal from the 
Executive Board 
4 Affiliate 
member 
 Organisations not part of an 
existing RS but with an 
interest in pursuing similar 
goals  
 Only legal entities duly 
constituted in accordance 
with the laws of their country 
of origin, can become an 
associate member  
 They are appointed by the 
GA upon proposal from the 
Executive Board 
In 
species 
Yes No No 
5 Observer  Individuals with an interest 
in AHA who may contribute 
to the work of the RSCN  
 They are appointed by the 
GA upon proposal from the 
Executive Board 
 Individuals working for 
lobbying groups or for 
organisations with a 
commercial purpose will not 
be accepted as observers. 
No Can only 
participate, in an 
advisory capacity 
in the GA, the 
WG and the 
conferences upon 
invitation by the 
Chair. 
No No 
Table 3. RSCN Membership categories 
 Originator 2016 RS 
name 
Adopter(s) 2016 RS name Contact person 
1 MACVIA-France 
Network (FR) 
1- Andalucia 
2- Aragon 
3- Campania  
4- Catalonia  
5- City of Helsinki 
6- Coimbra 
7- Heraklion 
8- Kohln-Bohn Region 
9- Life Tech Valley 
10- Liguria 
11- Lodz   
12- Medical Delta 
13- Milan Metropolitan - Bergamo Province 
14- NHS 24 
15- Northern Ireland 
16- Olomouc 
17- Pays de la Loire 
18- Porto  
19- Puglia 
20- Regione Piemonte 
21- Regione Toscany 
22- Region of Southern Denmark 
23- Turkey (Global Alliance Chronic  
24- ARIA Sweden 
25- ARIA Lithuania 
Jean Bousquet, MACVIA 
jean.bousquet@orange.fr  
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26- ARIA Argentina 
27- ARIA Australia 
28- ARIA Brazil 
29- ARIA Mexico 
2 Northern Ireland 
(UK) 
Catalonia (ES) Michael Scott, Northern Ireland (UK) 
email:  
DrMichael.Scott@northerntrust.hscni.net 
3 Northern Ireland 
(UK) 
Olomouc (CZ) Michael Scott, Northern Ireland (UK) 
email:  
4 Pays de la Loire 
(FR) 
Porto Metropolitan Area - Porto4Ageing (PT) Elísio Costa, Porto Metropolitan Area 
emcosta@ff.up.pt  
5 Northern Ireland 
(UK) 
North West Coast of England (UK) Michael Scott, Northern Ireland (UK) 
email:  
DrMichael.Scott@northerntrust.hscni.net 
6 Campania (IT) Asturias (ES) Ángel Retamar Arias, Asturias (ES) 
email: 
7 Lazio (IT) Porto Metropolitan Area - Porto4Ageing (PT) Elísio Costa, Porto Metropolitan Area 
emcosta@ff.up.pt  
8 Twente (NL) Campania (IT) Lex van Velsen 
email: 
9 Andalusia (ES) City of Zagreb (HR) Ana Carriazo 
anam.carriazo@juntadeandalucia.es  
10 Basque Country (ES) Nouvelle-Aquitaine (FR) Carole Doucet, Nouvelle-Aquitaine 
email: carole.doucet@nouvelle-
aquitaine.fr  
11 Medical Delta 
Rotterdam (NL) 
Campania (IT) Edwig Goossens 
email: 
12 Republic of Ireland 
Regional Network 
(COLLAGE) 
Campania (IT) 
Catalonia (ES) 
Metropolitan Area of Porto (Porto4Ageing) 
Rónán O'Caoimh (COLLAGE) 
ronan.ocaoimh@nuigalway.ie  
13 Basque Country (ES) Liguria (IT) Dolores Verdoy, Basque Country (ES) 
dverdoy@kronikgune.org  
14 Galicia (ES) City of Zagreb (BG) Susana Fernández Nocelo 
susana.fernandez.nocelo@sergas.es  
15 Scotland (UK) Basque Country (ES) Dolores Verdoy, Basque Country (ES) 
dverdoy@kronikgune.org  
16 Campania (IT) Olomouc (CZ) Zdenek Gütter, Olomouc (CZ) 
gutter@ntmc.cz  
17 Basque Country (ES) Scotland (UK) Donna Henderson, Scotland (UK) 
donna.henderson1@nhs.net  
18 North West Coast of 
England (UK) 
Oberbergischer Kreis (DE) Wolfgang Goetzke, Oberbergischer 
Kreis (DE) 
info@health-region.de  
19 Scotland (UK) Andalusia (ES) Ana Carriazo, Andalousia (ES) 
anam.carriazo@juntadeandalucia.es  
20 Andalusia (ES) City of Kraljevo (SRB) Milan Vukovic, City of Kraljevo (SRB) 
milan.vukovic@belit.co.rs  
Table 4. List of Twinnings 
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Figure 1: Twinning archetypes 
 
 
 
Lewin  Kotter  
Unfreezing  
Step 1: Establish a sense of urgency  
Step 2: Create a guiding coalition  
Step 3: Develop a vision and strategy  
Moving  
Step 4: Communicate the change vision  
Step 5: Empower others to act on the vision  
Step 6: Generate short-term wins  
Step 7: Consolidate gains and produce more change  
Refreezing  
Step 8: Anchor new approaches in the culture and institutionalize the 
changes 
Table 5: The Kotter’s model of change management -  Adapted from 
 
 
 
 
 
 
 
 
 
 
 
 
 
